2.2(top 20%)
impact factor
7.4K(top 5%)
papers
120.9K(top 5%)
citations
97(top 5%)
h-index
2.3(top 20%)
extended IF
8.3K
all documents
129.5K
doc citations
132(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Mechanism of thrombocytopenia in COVID-19 patientsAnnals of Hematology2020432
2Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiologyAnnals of Hematology2005407
3The IgG Fc receptor familyAnnals of Hematology1998356
4Epigenetic therapy in MDS and acute AML: focus on decitabineAnnals of Hematology2005286
5Apoptosis: mechanisms and relevance in cancerAnnals of Hematology2005279
6Blood type and outcomes in patients with COVID-19Annals of Hematology2020266
7Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cellsAnnals of Hematology2012247
8Antimicrobial therapy of unexplained fever in neutropenic patientsAnnals of Hematology2003233
9Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United StatesAnnals of Hematology2015225
10Anemia—still a major health problem in many parts of the world!Annals of Hematology2011210
11Postpartum anemia I: definition, prevalence, causes, and consequencesAnnals of Hematology2011210
12Von Willebrand factor: molecular size and functional activityAnnals of Hematology1996207
13Iron and pregnancy—a delicate balanceAnnals of Hematology2006199
14Mastocytosis: current concepts in diagnosis and treatmentAnnals of Hematology2002196
15Copper deficiency anemia: review articleAnnals of Hematology2018196
16Cytogenetic features in myelodysplastic syndromesAnnals of Hematology2008192
17A classification of acute leukaemia for the 1990sAnnals of Hematology1991190
18Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patientsAnnals of Hematology2010188
19Natural course and biology of CMLAnnals of Hematology2015187
20Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016Annals of Hematology2016173
21Epidemiology of chronic myeloid leukaemia: an updateAnnals of Hematology2015169
22Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Annals of Hematology2018168
23Vitamin D deficiency and anemia: a cross-sectional studyAnnals of Hematology2010166
24Primary adrenal lymphoma: a systematic reviewAnnals of Hematology2013162
25Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemiaAnnals of Hematology2005159
26Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOPAnnals of Hematology2008159
27Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignanciesAnnals of Hematology2003157
28Prepartum anaemia: prevention and treatmentAnnals of Hematology2008157
29Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myelomaAnnals of Hematology2000155
30The clinical importance of erythrocyte deformability, a hemorrheological parameterAnnals of Hematology1992153
31Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidaseAnnals of Hematology2003147
32Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Annals of Hematology2014147
33Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphomaAnnals of Hematology2012146
34The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosisAnnals of Hematology2014146
35Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcomeAnnals of Hematology2007144
36Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's diseaseAnnals of Hematology2002140
37Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patientsAnnals of Hematology2003139
38Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphomaAnnals of Hematology1994138
39Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)Annals of Hematology2017138
40Hematological findings in coronavirus disease 2019: indications of progression of diseaseAnnals of Hematology2020138
41COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registryAnnals of Hematology2021138
42A review of the European LeukemiaNet recommendations for the management of CMLAnnals of Hematology2015137
43Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOPAnnals of Hematology2004136
44Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cellsAnnals of Hematology2012136
45Beneficial and ominous aspects of the pleiotropic action of erythropoietinAnnals of Hematology2004134
46Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patientsAnnals of Hematology2010134
47Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementationAnnals of Hematology1998133
48RNA interference (RNAi) in hematologyAnnals of Hematology2004132
49The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancyAnnals of Hematology2014132
50Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysisAnnals of Hematology2008131